Colorectal tumor cells develop resistance to apoptosis signaling through Fas [47], [48], and Fas sensitivity decreases as tumor cells progress to advanced stage and metastatic disease phenotypes [49]. This evidence concerns the gene FAS and colorectal neoplasm.